Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan dose-response study in children aged 1-5 years with hypertension
2011-005991-40Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of valsartan in hypertension (HTN), sponsored by Novartis. Started Aug 2012; status: completed.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2011-005991-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005991-40.